Previously Healthy Young Adults with ‘Long COVID’ Show Vascular Dysfunction in Limbs, but Not Brain

Translate to Spanish or other 102 languages!

Researchers have examined the persistent effects of SARS-CoV-2 infection on the vascular function of otherwise healthy young adults. Image for illustration purposes.

Mega Doctor News

- Advertisement -

By American Physiological Society (APS)

Newswise — Rockville, Md. – In a first-of-its-kind study, researchers have examined the persistent effects of SARS-CoV-2 infection on the vascular function of otherwise healthy young adults. The research, published in the American Journal of Physiology-Heart and Circulatory Physiology, was chosen as an APSselect article for September.

It is intriguing that those with persistent [COVID-19] symptoms exhibited peripheral vascular dysfunction, whereas those who were asymptomatic at the time of testing had similar macrovascular and microvascular vasodilation to controls.

- Advertisement -

Adults 29 and younger make up only 16% of the U.S. population but account for over 7 million, or 22%, of U.S. COVID-19 infections. Though more research is needed to fully understand the extent of the problem, one study found that as many as 1 in 4 adults ages 18 to 39 reported symptoms weeks or months after the initial acute phase of COVID-19 infection. 

“Long COVID,” also called post-acute sequelae of SARS-COV-2 infection (PASC), is an umbrella term for the condition the U.S. Centers for Disease Control and Prevention refers to as “a lack of return to a usual state of health following acute COVID-19 illness.” Individuals with long COVID report a variety of symptoms, including cognitive impairment, headache and lightheadedness, which can be indicative of impairments to blood vessels supporting the brain.

Researchers from University of Texas at Arlington investigated brain and peripheral blood vessel function of 16 young adults who had tested positive for COVID-19 more than four weeks prior. Eight of the study subjects currently had COVID-19 symptoms and eight did not. Researchers then compared them to 12 peers who tested negative.

Symptomatic participants showed “significantly blunted” dilation of both large and small blood vessels in their limbs. However, despite previous studies showing stiffening of central arteries in young adults with acute COVID-19, long COVID participants in this study showed no such stiffening, nor did they show impaired function in the blood vessels that support the brain. Asymptomatic COVID-19–positive participants showed function similar to controls, offering hope that once symptoms resolve so may vascular impairments.

- Advertisement -

Read the full article, “Blunted peripheral but not cerebral vasodilator function in young otherwise healthy adults with persistent symptoms following COVID-19,” published in the American Journal of Physiology-Heart and Circulatory Physiology. It is highlighted as one of this month’s “best of the best” as part of the American Physiological Society’s APSselect program. Read all of this month’s selected research articles.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.
- Advertisement -